Mode
Text Size
Log in / Sign up
Phase 3 N=50 Randomized Triple-blind Treatment

Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache

Migraine Headache

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Verbal Pain Score at 60 Minutes — 4.5; 4.9 units on a scale (0-10)

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Normal saline (1000 mL) (Other); Control (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The Cooper Health System
Primary completion
Sep 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Verbal Pain Score at 60 Minutes
4.5; 4.9
SECONDARY
Verbal Pain Score at 120 Minutes
5.9; 5.5
SECONDARY
Percentage of Patients Free of Pain at 2 Hours
38; 32
SECONDARY
Percentage of Patients With no or Mild Functional Disability Due to Headache at 60 Minutes
72; 75
SECONDARY
Percentage of Patients Who Would Want the Same IV Fluid Treatment on a Future Visit
79; 67
SECONDARY
Percentage of Patients Who Needed Rescue Medications
21; 32
SECONDARY
Length of Stay
309; 316
SECONDARY
Verbal Pain Score at 48 Hours
2.6; 1.9
SECONDARY
Percentage of Patients Reporting no Nausea or Mild Nausea at 60 Minutes
88; 96

Summary

The purpose of this study is to determine whether patients in the emergency department with migraine headache who are administered an intravenous fluid bolus will report greater improvement in pain scores than control patients.

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Fluent in English
  • Meets International Classification of Headache Disorders (3rd ed) criteria for migraine headache:

A. At least five attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated)

C. Headache has at least two of the following four characteristics:

unilateral location pulsating quality moderate or severe pain intensity aggravation by or causing avoidance of routine physical activity (e.g. walking or climbing stairs)

D. During headache at least one of the following:

  • nausea and/or vomiting
  • photophobia and phonophobia E. Not better accounted for by another ICHD-3 diagnosis.

Exclusion Criteria

  • Intravenous Fluids are contraindicated in the opinion of the emergency department physician caring for the patient (ex patient has an exacerbation of congestive heart failure).
  • Intravenous fluids are required in the opinion of the emergency department physician caring for the patient (ex patient has intractable vomiting, patient has severe dehydration).
  • Have already received greater than or equal to 500 ml of intravenous fluid during this emergency department visit, prior to enrollment.
  • Currently pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02933060). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search